Background
Methods
Study group and study population
Sampling procedure and microbiological process of pneumococcal strains
Definitions of terms
Statistical analysis
Results
Study population and demographics
City/Prefecture | Total Number of children sampled | Number of pneumococcal strains isolated | Carriage rate % |
---|---|---|---|
Athens. Attika | 932 | 273 | 29.29% |
Halkida. Evia | 271 | 138 | 50.92%* |
Thessaloniki. Central Macedonia | 650 | 122 | 18.77%* |
Ioannina. Epirus | 59 | 26 | 44.07%* |
Alexandroupolis. Thrace | 102 | 34 | 33.33% |
Herakleion. Crete | 96 | 52 | 54.17%* |
Nafplio-Tripoli-Sparti. Peloponnese | 426 | 101 | 23.71% |
Greece in total
|
2536
|
746
|
29.42%
|
Nasopharyngeal carriage of S pneumoniae strains
Odds Ratio (OR) |
P
| 95% CI | |
---|---|---|---|
Gender (boys) | 1.019 | 0.827 | 0.855–1.211 |
Age (<3 years old) | 0.886 |
0.001
| 0.824–0.953 |
Private vs. public daycare centre | 0.862 | 0.128 | 0.712–1.043 |
Antibiotic consumption | |||
In the last month | 0.866 | 0.139 | 0.717–1.040 |
In the last trimester | 1.262 |
0.009
| 1.060–1.501 |
Siblings <8 ys in the family (yes or no) | 1.036 | 0.535 | 0.926–1.159 |
History of respiratory tract infections | 0.745 |
0.024
| 0.577–0.962 |
History of acute otitis media episodes | 1.098 | 0.288 | 0.923–1.306 |
Steroid use | 1.074 | 0.525 | 0.861–1.340 |
History of hospital admission | 0.751 | 0.296 | 0.439–1.285 |
Parents health-care workers | 1.176 | 0.210 | 0.912–1.517 |
Susceptibility testing
City/Prefecture | # strains | PG | CXM | CTX | ERY | COT | TET | CIP | |
---|---|---|---|---|---|---|---|---|---|
Athens. |
%ns-%r
| 37.9–15.8 | 29.8–28.7 | 1.8–0.4 | 33.2–32.1 | 43.6–26 | 24.2–23.4 | 3.8 | |
Attika | 273 |
MIC50/MIC90
| 0.023–2 | 0.047–4 | 0.023–0.75 | 0.125–256 | 0.5–32 | 0.125–24 | 0.75–1.5 |
Halkida. |
%ns-%r
| 37–15.2 | 23.9–21.7 | 1.4–0 | 39.1–37.7 | 51.8–29.2 | 34.8–30.4 | 3.8 | |
Evia | 138 |
MIC50/MIC90
| 0.023–2 | 0.032–3 | 0.023–0.75 | 0.125–256 | 0.75–32 | 0.19–32 | 0.75–2 |
Thessaloniki. |
%ns-%r
| 32.8–7.4* | 21.3–18 | 0.8–0 | 34.2–34.2 | 38–29.8 | 21.3–20.5 | 3.3 | |
Central Macedonia | 122 |
MIC50/MIC90
| 0.032–1 | 0.032–2 | 0.016–0.5 | 0.125–24 | 0.5–32 | 0.25–48 | 0.75–1.5 |
Ioannina. |
%ns-%r
| 19.2*-7.7* | 11.5–11.5 | 2.9–0 | 42.3–38.5 | 42.3–19.2 | 19.2–19.2 | 0 | |
Epirus | 26 |
MIC50/MIC90
| 0.032–1 | 0.047–3 | 0.023–0.38 | 0.25–96 | 0.5–18 | 0.125–24 | 0.5–1 |
Alexandroupolis. |
%ns-%r
| 11.8*-8.8* | 8.8–8.8 | 0–0 | 17.6*-17.6 | 35.3–2.9 | 14.7–11.8 | 11.8 | |
Thrace | 34 |
MIC50/MIC90
| 0.023–1 | 0.023–2 | 0.023–0.5 | 0.125–2.5 | 0.38–2 | 0.125–24 | 1–3 |
Herakleion. |
%ns-%r
| 53.8*-25.5* | 40.4–34.6 | 0–0 | 66.7*-66.7 | 65.4–26.9 | 48.1–46.2 | 6.1 | |
Crete | 52 |
MIC50/MIC90
| 0.12–2 | 0.5–6 | 0.12–0.75 | 32–256 | 1–32 | 1.5–96 | 0.75–1.5 |
Nafplio-Tripoli-Sparti. |
%ns-%r
| 28.0*-14.0* | 24.0–24.0 | 1.0–0.0 | 14.0*-14.0 | 30.0–20.0 | 21.0–21.0 | 2.0 | |
Peloponnese | 101 |
MIC50/MIC90
| 0.023–2 | 0.023–2 | 0.023–0.75 | 0.094–128 | 1–2 | 0.125–24 | 0.75–2 |
Greece in total
|
746
|
%ns-%r
|
34.8–14.1
|
25.7–23.9
|
1.3–0.1
|
33.8–33
|
43.8–25.2
|
26.3–24.8
|
4.0
|
MIC50/MIC90
|
0.023–1.5
|
0.032–3
|
0.023–0.75
|
0.125–256
|
0.5–32
|
0.125–24
|
0.75–2
|
Risk factors for carriage of resistant pneumococci
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
OR | 95%CI |
P
| OR | 95%CI |
P
| |
Penicillin resistance
| ||||||
Male gender | 0.75 | 0.49–1.15 | 0.196 | 0.76 | 0.48–1.19 | 0.244 |
Age <3 years old | 0.79 | 0.66–0.94 | 0.009 | 0.76 | 0.70–1.06 | 0.164 |
Sampling period* | 0.48 | 0.31–0.73 | 0.001 |
0.57
|
0.36–0.92
|
0.023
|
Antibiotic use in the last month | 1.94 | 1.26–2.98 | 0.002 |
2.00
|
1.26–3.17
|
0.003
|
Antibiotic use in the last trimester | 1.07 | 0.70–1.63 | 0.749 | 1.09 | 0.69–1.71 | 0.696 |
History of acute otitis media episodes | 1.07 | 0.70–1.63 | 0.749 | 0.90 | 0.54–1.51 | 0.709 |
History of respiratory tract infections | 0.89 | 0.50–1.58 | 0.652 | 0.96 | 0.48–1.92 | 0.928 |
Other sibling(s) in the household <8 years old | 0.96 | 0.62–1.47 | 0.814 | 1.07 | 0.67–1.71 | 0.751 |
Steroid use | 1.02 | 0.64–1.59 | 0.971 | 1.20 | 0.715–2.02 | 0.486 |
Admission to the hospital in the last year | 2.40 | 0.83–6.87 | 0.159 | 2.57 | 0.72–9.18 | 0.145 |
Prefecture of Thessaloniki** | 0.42 | 0.19–0.9 | 0.026 |
0.33
|
0.13–0.83
|
0.019
|
Prefecture of Evia(Halkida)** | 1.11 | 0.66–0.87 | 0.685 | 0.91 | 0.43–1.94 | 0.825 |
Prefecture of Evros(Alexandroupolis)** | 0.57 | 0.17–1.92 | 0.458 | 0.52 | 0.14–1.91 | 0.328 |
Prefecture of Epirus(Ioannina)** | 0.49 | 0.11–2.13 | 0.564 | 0.20 | 0.01–1.30 | 0.635 |
Prefecture of Peloponnese** | 0.98 | 0.53–1.81 | 1.000 | 1.09 | 0.52–2.29 | 0.803 |
Prefecture of Herakleion, Crete** | 2.17 | 1.11–4.22 | 0.036 | 1.69 | 0.70–4.07 | 0.238 |
Erythromycin resistance
| ||||||
Male gender | 1.06 | 0.78–1.45 | 0.693 | 1.00 | 0.72–1.39 | 0.958 |
Age <3 years old | 0.82 | 0.72–0.94 | 0.005 | 0.866 | 0.74–1.00 | 0.061 |
Sampling period* | 0.46 | 0.33–0.63 | < 0.001 |
0.52
|
0.37–0.73
|
< 0.001
|
Antibiotic use in the last month | 1.43 | 1.04–1.96 | 0.025 |
1.92
|
1.35–2.72
|
< 0.001
|
Antibiotic use in the last trimester | 1.19 | 0.87–1.63 | 0.266 | 1.30 | 0.94–1.80 | 0.112 |
History of acute otitis media episodes | 1.39 | 1.02–1.90 | 0.034 | 1.13 | 0.78–1.64 | 0.508 |
History of respiratory tract infections | 0.78 | 0.50–1.20 | 0.262 |
0.57
|
0.34–0.95
|
0.031
|
Other sibling(s) in the household <8 years old | 0.93 | 0.68–1.28 | 0.686 | 0.89 | 0.63–1.26 | 0.534 |
Steroid use | 1.33 | 0.96–1.84 | 0.081 | 1.20 | 0.81–1.77 | 0.356 |
Admission to the hospital in the last year | 0.77 | 0.27–2.19 | 0.801 | 0.87 | 0.23–3.23 | 0.846 |
Prefecture of Thessaloniki** | 1.06 | 0.70–1.61 | 0.752 | 0.99 | 0.56–1.75 | 0.993 |
Prefecture of Evia(Halkida)** | 1.29 | 0.87–1.89 | 0.194 | 1.03 | 0.59–1.78 | 0.913 |
Prefecture of Evros(Alexandroupolis)** | 0.42 | 0.17–1.03 | 0.061 | 0.50 | 0.19–1.32 | 0.165 |
Prefecture of Epirus(Ioannina)** | 1.28 | 0.57–2.86 | 0.531 | 1.39 | 0.51–3.80 | 0.516 |
Prefecture of Peloponnese** | 0.36 | 0.36–0.97 | 0.017 |
0.41
|
0.21–0.81
|
0.010
|
Prefecture of Herakleion, Crete** | 4.22 | 2.24–7.98 | < 0.001 |
3.26
|
1.55–6.84
|
0.002
|
Penicillin nonsusceptibility
| ||||||
Male gender | 0.89 | 0.79–1.47 | 0.638 | 0.89 | 0.65–1.23 | 0.499 |
Age <3 years old | 0.78 | 0.68–0.89 | < 0.001 |
0.82
|
0.71–0.96
|
0.013
|
Sampling period* | 0.5 | 0.37–0.69 | < 0.001 |
0.58
|
0.42–0.82
|
0.002
|
Antibiotic use in the last month | 1.71 | 1.23–2.38 | 0.001 |
1.66
|
1.17–2.35
|
0.004
|
Antibiotic use in the last trimester | 1.36 | 1.00–1.84 | 0.045 |
1.48
|
1.07–2.04
|
0.017
|
History of acute otitis media episodes | 1.04 | 0.77–1.41 | 0.815 | 0.82 | 0.56–1.18 | 0.297 |
History of respiratory tract infections | 1.06 | 0.68–1.65 | 0.825 | 1.13 | 0.68–1.89 | 0.624 |
Other sibling(s) in the household <8 years old | 0.84 | 0.61–1.28 | 0.686 | 0.85 | 0.61–1.20 | 0.379 |
Steroid use | 1.30 | 0.95–1.79 | 0.102 | 1.36 | 0.93–2.01 | 0.108 |
Admission to the hospital in the last year | 1.52 | 0.59–3.91 | 0.453 | 1.97 | 0.61–6.32 | 0.251 |
Prefecture of Thessaloniki** | 0.89 | 0.59–1.35 | 0.678 | 0.48 | 0.27–0.86 |
0.014
|
Prefecture of Evia(Halkida)** | 1.12 | 0.76–1.64 | 0.554 | 0.73 | 0.42–1.26 | 0.265 |
Prefecture of Evros(Alexandroupolis)** | 0.21 | 0.074–0.63 | 0.005 | 0.19 | 0.06–0.57 |
0.003
|
Prefecture of Epirus(Ioannina)** | 0.43 | 0.16–1.16 | 0.098 | 0.17 | 0.03–0.81 |
0.026
|
Prefecture of Peloponnese** | 0.69 | 0.43–1.10 | 0.143 | 0.70 | 0.40–1.22 | 0.215 |
Prefecture of Herakleion, Crete** | 1.91 | 1.05–3.48 | 0.003 | 1.39 | 0.68–2.62 | 0.357 |
Erythromycin nonsusceptibility
| ||||||
Male gender | 1.08 | 0.79–1.47 | 0.638 | 1.02 | 0.74–1.41 | 0.881 |
Age <3 years old | 0.8 | 0.7–0.92 | 0.002 |
0.84
|
0.72–0.97
|
0.023
|
Sampling period* | 0.46 | 0.34–0.64 | < 0.001 |
0.53
|
0.37–0.74
|
< 0.001
|
Antibiotic use in the last month | 1.81 | 1.3–2.52 | < 0.001 |
1.86
|
1.31–2.64
|
< 0.001
|
Antibiotic use in the last trimester | 1.44 | 1.05–1.97 | 0.021 | 1.32 | 0.95–1.82 | 0.091 |
History of acute otitis media episodes | 1.44 | 1.06–1.96 | 0.019 | 1.16 | 0.80–1.67 | 0.426 |
History of respiratory tract infections | 0.77 | 0.50–1.19 | 0.263 | 0.65 | 0.34–0.94 |
0.028
|
Other sibling(s) in the household <8 years old | 0.97 | 0.71–1.33 | 0.873 | 0.92 | 0.65–1.30 | 0.662 |
Steroid use | 1.26 | 0.91–1.73 | 0.610 | 1.13 | 0.77–1.67 | 0.519 |
Admission to the hospital in the last year | 0.74 | 0.26–2.11 | 0.802 | 0.86 | 0.23–3.17 | 0.820 |
Prefecture of Thessaloniki** | 1.02 | 0.67–1.54 | 0.916 | 0.92 | 0.52–1.62 | 0.794 |
Prefecture of Evia(Halkida)** | 1.33 | 0.90–1.95 | 0.162 | 1.12 | 0.65–1.94 | 0.671 |
Prefecture of Evros(Alexandroupolis)** | 0.40 | 0.16–0.99 | 0.042 | 0.46 | 0.17–1.21 | 0.120 |
Prefecture of Epirus(Ioannina)** | 1.45 | 0.65–3.22 | 0.399 | 1.59 | 0.60–4.25 | 0.347 |
Prefecture of Peloponnese** | 0.34 | 0.12–0.92 | 0.002 |
0.38
|
0.2–0.75
|
0.005
|
Prefecture of Herakleion, Crete** | 4.02 | 2.13–7.58 | < 0.001 |
3.39
|
1.61–7.17
|
0.005
|
Use of antibiotics and resistance
Serotype distribution
Athens
(n, %)
|
Halkida
(n, %)
|
Thessaloniki
(n, %)
|
Ioannina
(n, %)
|
Alexandroupolis
(n, %)
|
Herakleion
(n, %)
|
Peloponnese
(n, %)
|
Total
(n,%)
| |
---|---|---|---|---|---|---|---|---|
PCV7* serotypes | 80 (70.17) | 42 (73.68) | 33 (58.92) | 10 (76.92) | 6 (54.55) | 25 (75.76) | 30 (90.91) | 226 (71.29) |
19F
| 32 (28.07) | 20 (35.09) | 9 (16,07) | 2 (15.38) | 3 (27.27) | 11 (33.33) | 10 (30.3) | 87 (27.44) |
14
| 10 (8.77) | 6 (10.53) | 10 (17.86) | 11 (33.33) | 3 (9.09) | 40 (12.62) | ||
9V
| 20 (17.54) | 2 (3.57) | 2 (15.38) | 10 (30.3) | 34 (10.73) | |||
23F
| 10 (8.77) | 6 (10.53) | 6 (10.71) | 5 (38.46) | 1 (9.09) | 1 (3.04) | 4 (12.13) | 33 (10.41) |
6B
| 8 (7.02) | 10 (17.54) | 5 (8.93) | 1 (7.69) | 2 (18.18) | 2 (6.06) | 2 (6.06) | 30 (9.46) |
18C
| 1 (1.79) | 1 (3.03) | 2 (0.63) | |||||
PCV7-related serotypes
|
17 (14.92)
|
10 (17.55)
|
11 (19.66)
|
0
|
2 (18.18)
|
4 (12.12)
|
0
|
43 (13.56)
|
6A
| 7 (6.14) | 3 (5.26) | 5 (8.93) | 0 | 2 (6.06) | 17 (5.36) | ||
Other related
| 10 (8.78) | 7 (12.29) | 6 (10.73) | 2 (18.18) | 2 (6.06) | 26 (8,20)) | ||
Non PCV7 serogroups
|
10 (8.77)
|
3 (5.26)
|
8 (14.28)
|
3 (23.08)
|
1 (9.09)
|
2 (6.06)
|
3 (9.09)
|
32 (10.1)
|
Nontypeable strains
|
7 (6.14)
|
2 (3.51)
|
4 (7.14)
|
0
|
2 (18.18)
|
2 (6.06)
|
0
|
16 (5.05)
|
Total
| 114 (100) | 57 (100) | 56 (100) | 13 (100) | 11 (100) | 33 (100) | 33 (100) | 317 (100) |